UNSPSC 51202415: Ramucirumab

A human vascular endothelial growth factor receptor 2 (VEGFR2) antagonist indicated for the treatment of Gastric Cancer.

UNSPSC 51202415 Ramucirumab is a Commodity code nominally identifying a specific monoclonal antibody therapeutic, but recent state and local solicitations tagged to this code show a substantial disconnect: the opportunities actually posted do not procure ramucirumab or related oncology drugs, but instead address naloxone, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and direct-to-manufacturer pharmacy programs. The code shows no recent activity aligned with its nominal pharmaceutical product scope. State and local governments sourcing under this code number are issuing RFPs, RFQs, and ITBs through county health departments, municipal fire and rescue divisions, state health and human services agencies, and cooperative purchasing alliances that span multiple states and local jurisdictions.

The geographic spread of recent activity includes Florida (Seminole County), Texas (HHS Commission), and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) serving Minnesota and Oregon. Representative recent opportunities include an IFB from Seminole County, Florida (Solicitation IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 drug deactivation systems annually; an RFI from Texas HHS Commission (HHS0017013, posted April 3, 2026) exploring direct-to-manufacturer prescription programs; an ITB from the City of Tampa (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies supporting the Tampa Fire Department Rescue Division with an estimated contract value of $700,000, sheltered for certified Small Local Business Enterprises with a 5 percent bid discount; and an RFP from MMCAP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers. The code's current tagging appears inconsistent with procurement intent and warrants clarification from issuing bodies before pursuing opportunities under this code number.